Company / EPS (Diluted)
Vanda Pharmaceuticals Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.04
FY2025
5-year range
$0.04 / $2.11
FY2021-FY2025
Trend
-63.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 10 years, ranging from $-0.94 in FY2017 to $2.11 in FY2021.
Based on SEC 10-K filings.
0.04 in FY2025 with a 5-year CAGR of -39.2%.
Declined from $0.58 to $0.04 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -54.3%
- 5-Year CAGR
- -39.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 63.6% year-over-year.
- Peak eps (diluted) was recorded in FY2021.
- Lowest eps (diluted) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | -63.6% |
| FY2024 | $0.11 | -81.0% |
| FY2023 | $0.58 | +38.1% |
| FY2022 | $0.42 | -80.1% |
| FY2021 | $2.11 | +339.6% |
| FY2020 | $0.48 | +237.1% |
| FY2019 | -$0.35 | +14.6% |
| FY2018 | -$0.41 | +56.4% |
| FY2017 | -$0.94 | -270.9% |
| FY2016 | $0.55 | +179.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026